By activating adaptive immunity, scientists plan to train the body to fight aging cells on its own, prolonging the period of active life. The project will be completed in 2026, but experts warn of the difficulties the team may face.
According to the developers of the vaccine, the main factor contributing to the development of age-related diseases is a decrease in immunity. This leads to frequent and prolonged infections and the inability of the body to get rid of aging cells, writes RuNews24.ru.
The project is in its initial stage, and its completion is scheduled for 2026.
According to project manager Daniil Shevyrev, the essence of the approach is to restore the body's ability to remove old cells from tissues using adaptive immunity mechanisms.
This is a complex and non-trivial task with many obstacles and pitfalls, but even a partial solution will create the potential to develop personalized approaches to prolong a healthy old age.
Currently, scientists are developing and testing methods to stimulate T-cell immunity against aging cells. First, their effectiveness and safety will be tested in vitro, then on mice and primates, as the model organism closest to humans.
The results of the project will lay the foundations for the development of personalized therapeutic approaches to prevent or mitigate the negative effects of aging.
